Patent details

Herbas

VPB

Print

EN | LT

LT - SUBSTITUTED QUINAZOLINE COMPOUND HAVING BLOOD-BRAIN BARRIER PENETRATION CAPABILITY

EN - SUBSTITUTED QUINAZOLINE COMPOUND HAVING BLOOD-BRAIN BARRIER PENETRATION CAPABILITY

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 405/14
		C07D 401/12
		A61K 31/517
		A61P 35/00
		A61P 25/28

European patent
(11)	Number of the document	3438107
(13)	Kind of document	T
(96)	European patent application number	17869669.6
	Date of filing the European patent application	2017-10-17
(97)	Date of publication of the European application	2019-02-06
(45)	Date of publication and mention of the grant of the patent	2020-06-10
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/CN2017/106616
	Date	2017-10-17

PCT application publication
(87)	Number	WO 2018/086446
	Date	2018-05-17

Priority applications
(30)	Number	Date	Country code
	201610982608	2016-11-08	CN

Inventors
(72)	ZHONG, Wei, CN

Grantee
(73)	Weishang (Shanghai) Bio-Pharmaceutical Co., Ltd., Room E8, 3rd Floor, Building 6 No.4299 Jindu Road Minhang District, Shanghai 201108, CN

Title
(54)	SUBSTITUTED QUINAZOLINE COMPOUND HAVING BLOOD-BRAIN BARRIER PENETRATION CAPABILITY
	SUBSTITUTED QUINAZOLINE COMPOUND HAVING BLOOD-BRAIN BARRIER PENETRATION CAPABILITY